Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
AstraZeneca
Express Scripts
Farmers Insurance
Colorcon
UBS
Baxter
Teva
US Army

Generated: September 23, 2018

DrugPatentWatch Database Preview

Hydroxyzine pamoate - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydroxyzine pamoate and what is the scope of hydroxyzine pamoate freedom to operate?

Hydroxyzine pamoate is the generic ingredient in three branded drugs marketed by Teva, Barr, Duramed Pharms Barr, Heritage Pharma, Impax Labs Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Superpharm, Vangard, Watson Labs, and Pfizer, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for hydroxyzine pamoate. Thirty-six suppliers are listed for this compound.

Pharmacology for hydroxyzine pamoate
Drug ClassAntihistamine
Mechanism of ActionHistamine Receptor Antagonists
Synonyms for hydroxyzine pamoate
(+-)-2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)
1-(p-chloro-|A-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine, pamoate
10246-75-0
2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)
2-(2-{4-[(4-CHLOROPHENYL)(PHENYL)METHYL]PIPERAZIN-1-YL}ETHOXY)ETHAN-1-OL; 4-[(3-CARBOXY-2-HYDROXYNAPHTHALEN-1-YL)METHYL]-3-HYDROXYNAPHTHALENE-2-CARBOXYLIC ACID
2-naphthoic acid, 4,4'-methylenebis[3-hydroxy-, hydroxyzine salt (6ci)
4-[(3-carboxy-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid; 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
4-[(3-Carboxy-2-hydroxy-naphthalen-1-yl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid; 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid; 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol
AC1L18EU
AK322054
AKOS015914218
Atarax P
Atarax-P (TN)
Bobsule
BSPBio_002166
C23H16O6.C21H27ClN2O2
CCG-40218
CHEMBL1200467
CTK0H5141
D01096
DivK1c_000503
EBD55260
EINECS 233-582-1
Equipose
Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, (+-)-, compd. with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (1:1)
Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, compd. with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (1:1)
FT-0697190
HE073412
HMS1920F11
HMS2091L19
HMS2235O19
HMS501J05
HY-B0895
Hy-Pam
HY-PAM "25"
Hydroxyzine (pamoate)
Hydroxyzine embonate
Hydroxyzine pamoate (JP17/USP)
Hydroxyzine pamoate [USAN:JAN]
Hydroxyzine pamoate [USP:JAN]
Hydroxyzine pamoate salt
Hydroxyzine pamoate salt, analytical standard
Hydroxyzine pamoate, United States Pharmacopeia (USP) Reference Standard
HYDROXYZINE; PAMOIC ACID
hydroxyzinepamoate,usp
Hydroxyzyne pamoate
HYYDROXYZINE PAMOATE
I14-44826
IDI1_000503
J-000695
KBio1_000503
KBio2_001391
KBio2_003959
KBio2_006527
KBio3_001386
KBioGR_000385
KBioSS_001391
LS-171818
MFCD00058051
MLS000028605
MolPort-003-666-206
NCGC00021152-02
NCGC00021152-03
NCGC00094698-01
NCGC00094698-02
NINDS_000503
NSC-757063
NSC757063
Paxisitil
Pharmakon1600-01500345
PL039893
SBI-0051413.P003
SCHEMBL41333
SMR000058728
SPBio_001099
Spectrum_000911
SPECTRUM1500345
Spectrum2_001000
Spectrum3_000463
Spectrum4_000013
Spectrum5_000838
SR-01000003149
SR-01000003149-4
Vistaril pamoate (TN)

US Patents and Regulatory Information for hydroxyzine pamoate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 081128-001 Jun 28, 1991 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 087479-001 Approved Prior to Jan 1, 1982 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Barr HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 088496-001 Jun 15, 1984 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 086698-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pfizer VISTARIL hydroxyzine pamoate CAPSULE;ORAL 011459-004 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
AstraZeneca
Express Scripts
Farmers Insurance
Colorcon
UBS
Baxter
Teva
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.